340B State Law Contract Pharmacy Decisions

Several states have enacted laws protecting 340B contract pharmacy arrangements by requiring drug manufacturers to honor discounted pricing at those locations to preserve patient access. Manufacturers have challenged these laws in courts nationwide. This webpage compiles decisions in those cases as they are issued.

State Law Upheld
CaseCourtDate Decision IssuedDecision Document
Novartis Pharms. Corp. v. Fitch5th Cir.4/9/2026PDF
PhRMA v. Fitch5th Cir.4/9/2026PDF
PhRMA v. WeiserD. Colo.3/18/2026PDF
AbbVie v. SkrmettiD. Tenn.2/26/2026PDF
AstraZeneca Pharms. LP v. LopezD. Haw.2/23/2026PDF
PhRMA v. EllisonMinn. Court of Appeals2/17/2026PDF
AbbVie v. Murrill5th Cir.2/9/2026PDF
PhRMA v. FreyD. Me.1/23/2026PDF
AbbVie Inc. v. JackleyD.S.D.12/22/2025PDF
AbbVie Inc. v. HilgersD. Neb.12/19/2025PDF
AbbVie Inc. v. WeiserD. Colo.10/31/2025PDF
AbbVie Inc. v. NeronhaD.R.I.9/30/2025MSG (ZIP download)
AstraZeneca Pharms. LP v. WeiserD. Colo.9/30/2025PDF
Novartis Pharms. Corp. v. FreyD. Me.9/23/2025PDF
AbbVie Inc. v. Fitch5th Cir.9/12/2025PDF
AbbVie Inc. v. SkrmettiM.D. Tenn.6/30/2025PDF
PhRMA v. EllisonMinn. Dist. Ct.4/15/2025PDF
AstraZeneca Pharms. LP v. FitchS.D. Miss.12/23/2024PDF
PhRMA v. MurrillW.D. La.9/30/2024PDF
Novartis Pharms. Corp. v. BrownD. Md.9/5/2024PDF
AbbVie Inc. v. FitchS.D. Miss.7/22/2024PDF
Novartis Pharms. Corp. v. FitchS.D. Miss.7/1/2024PDF
PhRMA v. FitchS.D. Miss.7/1/2024PDF
PhRMA v. McClain8th Cir.3/12/2024PDF
Mixed/Inconclusive
CaseCourtDate Decision IssuedDecision Document
AbbVie and PhRMA v. LopezD. Haw.2/19/2026PDF
PhRMA v. ArelD. Vt.12/29/2025PDF
AbbVie Inc. v. BrownD. Utah11/19/2025PDF
AstraZeneca Pharms. LP v. HarrisE.D. Ark.9/30/2025PDF
AstraZeneca Pharms. LP v. BailevW.D. Mo.2/27/2025PDF
Novartis Pharms. Corp. v. BaileyW.D. Mo.2/13/2025PDF
State Law Enjoined
CaseCourtDate Decision IssuedDecision Document
PhRMA v. McCuskey4th Cir.3/31/2026PDF
AbbVie Inc. v. DrummondW.D. Okla.10/31/2025PDF
PhRMA v. MorriseyS.D. W. Va.12/17/2024PDF

Related Resources

Testimony
AHA House E&C Testimony on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape
Public
Letter/Comment
AHA Letter to HRSA Regarding a New Concerning Development with the 340B Program
Public
Case Studies
Good Samaritan | Indiana
Public
Special Bulletin
Use Revised AHA Model Letter to Submit Comments on 340B Rebate Model RFI by New April 20 Deadline
Member
Letter/Comment
AHA Comments on CMS Proposed GLOBE Model
Public
Action Alert
Action Alert on 340B Rebate Model RFI
Member